Treatment of Influenza A with Amantadine and Rimantadine. This treatment has been replaced by neuraminidase inhibitors and is no longer used in the USA. No valid studies conducted. Therefore, no data exists on benefits. Both drugs have irritating stomach and gut effects, while Amantadine may also impair the nervous system and lead to psychiatric symptoms.
Avoid this treatment:
No data exists on benefits for seniors, and these treatments are possibly dangerous and were discontinued by the manufacturer in the USA.
Antiviral drugs (Symmetrel and Flumadine)
Seniors with Flu, 65 year old and above
Amantadine or Rimantadine, usually 100 mg orally, twice a day for 7 days
Treatment of Influenza A infection, symptoms and complications
Unknown. No valid clinical trials.
Common side effects include nausea, loss of appetite, constipation or diarrhea, and upset stomach and rash for both drugs, while for Amantadine can also have serious effects on the nervous system, leading to concentration difficulties and psychiatric symptoms.
Flu (influenza A virus infection and symptoms).
Symptoms and signs:
Cough, dizziness, fever, headache, nausea, pains, runny nose, sore throat, vomiting and aches.
Ear infection, lung infection, Seizures.
Visitors at this page also visited
Amantadine (trade name Symmetrel, by Endo Pharmaceuticals) is a drug that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian drug. Rimantadine (INN, sold under the trade name Flumadine) is an orally administered antiviral drug used to treat, and in rare cases prevent, influenza virus A infection. Both rimantadine and Amantadine are derivates of adamantane. (source)
Similar pages on this site
Good to know
Biotech stocks plunge after FDA makes it easier for public to search for…